ETFs & Funds
By targeting the hypoxic niche,
Th-302 can kill CSCs, where CSCs are known to reside. Killing CSCs are key to cancer tx.
Add a reply...
Latest StockTalks »
people get THLD breaking news and analysis by email alert.
Get email alerts on THLD »
Threshold Pharmaceuticals, Inc.
Get latest price
From other sites
Threshold Pharmaceuticals’ stock plunges after drug trial disappoints
at MarketWatch.com (Dec 7, 2015)
Threshold Pharmaceuticals : Announces Presentation and Webcast at the Stifel 2015 Healthcare Conference
at 4-traders.com (Nov 11, 2015)
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
at Benzinga.com (Dec 31, 2014)
Stocks to Watch: WFC, TSLA, NFLX & More
at CNBC.com (Sep 17, 2012)
Movers & Shakers: Monday’s biggest gaining and declining stocks
at MarketWatch.com (Sep 17, 2012)